INSIGHTS ON REGULATORY COMPLIANCE

• Development Of An Effective LC-MS/MS Cleaning Validation Method

  Gain insight into a robust LC-MS/MS method for quantifying therapeutic peptides that supports contamination control and cleaning validation to ensure product safety and integrity.

• Advancing Clean Manufacturing Through Contamination Control That Never Compromises

  Hear how real-time contamination monitoring helps life sciences teams protect yield and ensure sterility. Discover smarter ways to defend product integrity and respond confidently to contamination risks.

• Active Air Sampler Comparison In Remote Settings

  Discover how optimized air sampler geometry improves microbial collection efficiency and continuous environmental monitoring accuracy to safeguard critical cleanroom operations.

• Maximize Operational Readiness And Efficiency Without Compromising Quality

  Discover how digital transformation drives efficiency, agility, and compliance in pharmaceutical manufacturing to optimize processes, improve quality, and accelerate time-to-market.

• GLP-1 Peptides Around The World

  8/12/2026

  Explore how evolving regulations, supply constraints, and reimbursement models shape GLP-1 drug development across the U.S., Europe, and Asia.

• Manufacturing Made More Robust And Customer-Centric

  12/11/2025

  Discover how regional manufacturing, risk-aware practices, and agile strategies are reshaping supply chains to deliver resilience, transparency, and sustainability in today’s complex global environment.

• The Invaluable Asset Driving Advanced Therapies Forward

  6/19/2026

  Cell therapies are advancing rapidly, but manufacturing delays still limit patient access. Improving operational understanding, reducing risk, and strengthening collaboration may be just as critical.

• 2025 And Beyond: Another Look At Upcoming NDSRI Regulations

  8/21/2025

  The presence of nitrosamine drug substance-related impurities (NDSRIs) in medications has become an urgent issue for the pharmaceutical industry. Understand the acceptable intake (AI) limits.

• MIDBA: A New Regulatory Approach To Clinical Device Bridging

  8/12/2026

  When devices evolve, evidence expectations can shift. Explore a risk-based clinical bridging approach to support regulatory decisions.